Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B

Colorado life sciences companies raise $750M in 2019, Pfizer acquisition of Array BioPharma brings total to $12.1B

DENVER -- Colorados life sciences ecosystem raised $750 million in 2019, with funds from federal and state grants, successful financing rounds and acquisitions. The record-breaking acquisition of... Read More

Wednesday December 18, 2019 Tags: Denver, Colorado BioScience Association, Jennifer Jones Paton, Array BioPharma, Clovis Oncology, Inscripta, Emily Roberts

CBSA delivers awards to top bioscience leaders

CBSA delivers awards to top bioscience leaders

DENVER -- Colorado BioScience Association celebrated the companies and organizations developing life-saving breakthroughs at its Annual Awards Dinner held Nov. 7 at the Hyatt Regency in Denver.... Read More

Tuesday November 12, 2019 Tags: Denver, Colorado BioScience Association, Jennifer Jones Paton, Biodesix, Securisyn, Agilent Technologies, TOLMAR, Array BioPharma, Scott Larson

Array BioPharma: Cancer drug showing favorable results in phase 3 trials

Array BioPharma: Cancer drug showing favorable results in phase 3 trials

BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced the presentation of results from the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI (encorafenib), a BRAF... Read More

Monday July 8, 2019 Tags: Boulder, Array BioPharma, Scott Kopetz

Array BioPharma to be acquired by drug giant Pfizer for $11.4B

Array BioPharma to be acquired by drug giant Pfizer for $11.4B

BOULDER -- Drug manufacturing giantPfizer and Array BioPharma today announced they have entered into a definitive merger agreement under which Pfizer will acquire Array, a Boulder-based... Read More

Monday June 17, 2019 Tags: Boulder, Array BioPharma, Pfizer, Ron Squarer

Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care

Array BioPharma drugs recommended by National Comprehensive Cancer Network for CR care

BOULDER -- Array BioPharma Inc. (NASDAQ: ARRY) announced the National Comprehensive Cancer Network(NCCN) has updated their Clinical Practice Guidelines in Oncology for Colon and Rectal Cancer to... Read More

Tuesday March 19, 2019 Tags: Boulder, Array BioPharma, Ron Squarer

Array BioPharma announces positive results for cancer drug combo

Array BioPharma announces positive results for cancer drug combo

BOULDER -- Array BioPharma Inc . (Nasdaq: ARRY) today announced updated safety and efficacy results, including mature overall survival (OS), from the safety lead-in of the Phase 3 BEACON CRC... Read More

Tuesday January 15, 2019 Tags: Boulder, Array BioPharma, Victor Sandor

European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment

European Commission approves Array's encorafenib and binimetinib combo for melanoma treatment

BOULDER -- Array BioPharma Inc . (NASDAQ: ARRY) today announced the European Commission (EC) has approved BRAFTOVI (encorafenib) in combination with MEKTOVI (binimetinib) for the treatment of... Read More

Friday September 21, 2018 Tags: Denver, Array BioPharma, Ron Squarer, encorafenib, binimetinib

Array BioPharma names Carrie S. Cox chair of its board of directors

Array BioPharma names Carrie S. Cox chair of its board of directors

BOULDER -- Array BioPharma Inc. (Nasdaq: ARRY) today announced Carrie S. Cox has been named chair of its board of directors effective immediately. Cox has been appointed to the Audit and... Read More

Tuesday August 14, 2018 Tags: Boulder, Array BioPharma, Carrie Cox, Ron Squarer